Physician

Anya Elizabeth Bandt, M.D.

According to 2025 Medicare claims, Anya Bandt, M.D. (NPI: 1750401998) practices dermatology in the Santa Rosa-Petaluma, CA market, with the plurality of this provider's patient population coming from Sonoma, CA. This provider's primary affiliated billing organization is EYE ASSOCIATES OF SEBASTOPOL MEDICAL GROUP INC (NPI: 1295729382; TIN: 680413229) and primary practice location at 95472-4270.

Bandt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 668 traditional Medicare patients, billed 8,812 HCPCS/CPT codes, and received $609,802 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 944 prescription claims across 377 beneficiaries totaling $167,462 in drug costs, led by Jublia (Efinaconazole). Open Payments data shows 22 records totaling $642. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $43,541 and ending at $167,462. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	503	6,991	$427,589
2016	431	6,457	$312,374
2017	382	3,950	$266,112
2018	336	3,297	$252,324
2019	305	7,373	$274,464
2020	279	16,712	$258,366
2021	300	12,022	$292,762
2022	318	11,161	$258,273
2023	471	8,337	$365,026
2024	668	8,812	$609,802

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	149	420	$43,541
2016	138	375	$26,621
2017	137	398	$32,135
2018	131	337	$14,288
2019	112	281	$15,044
2020	111	303	$18,902
2021	132	357	$20,987
2022	146	367	$14,800
2023	195	483	$24,907
2024	377	944	$167,462

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	197	293	$447
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	273	390	$64
11102	Biopsy of related skin growth, first growth	197	253	$64
17000	Destruction of precancer skin growth, 1 growth	268	347	$37
17003	Destruction of precancer skin growth, 2-14 growths	238	1,170	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jublia	Efinaconazole	13	390	$13,451
Xarelto	Rivaroxaban	11	330	$6,133
Metronidazole	Metronidazole	37	1,455	$2,028
Fluocinonide	Fluocinonide	24	780	$1,376
Mupirocin	Mupirocin	179	3,383	$1,365

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$642	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anya Elizabeth Bandt, M.D.?

Tedicare shows public-source Medicare data for Anya Elizabeth Bandt, M.D. (NPI 1750401998), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anya Elizabeth Bandt, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anya Elizabeth Bandt, M.D.?

Anya Elizabeth Bandt, M.D. is linked to EYE ASSOCIATES OF SEBASTOPOL MEDICAL GROUP INC (billing NPI 1295729382) in the available physician profile data.

Does Anya Elizabeth Bandt, M.D. have Open Payments data?

Anya Elizabeth Bandt, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.